Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia

C. Rodrigo, T. Bewick, S. Greenwood, W.S. Lim (Nottingham, United Kingdom)

Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Session: Prognostic indices in respiratory infections
Session type: Thematic Poster Session
Number: 2515
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Rodrigo, T. Bewick, S. Greenwood, W.S. Lim (Nottingham, United Kingdom). Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia. Eur Respir J 2012; 40: Suppl. 56, 2515

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009

Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
Source: ERJ Open Res, 2 (4) 00011-2016; 10.1183/23120541.00011-2016
Year: 2016



Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008


Biological markers in hospitalised patients with community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Clinical presentation and evolution of community acquired pneumonia in older patients
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012


Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003


Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group
Source: Eur Respir J 2004; 24: Suppl. 48, 714s
Year: 2004

Effect of pneumococcal conjugate vaccination on radiological findings of chest in infants hospitalized with community acquired pneumonia in northern India: a case-control study
Source: International Congress 2019 – Epidemiology of childhood respiratory diseases
Year: 2019


Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Comparison of H1N1 associated pneumonia with community acquired pneumonia in hospitalized patients
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010


Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010

Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004